Current Executive Committee
Members of the Executive Committee are Masters of the Society.
President: Gregory A. Poland, MD, MACP, FIDSA, DHL(hon)
Gregory A. Poland, M.D., is the director of Mayo Clinic’s Vaccine Research Group – a state-of-the-art research group and laboratory that seeks to understand the genetic drivers of viral vaccine response and investigates issues surrounding novel vaccines important to public health. The Poland lab has developed the field of viral vaccine immunogenetics, the immune response network theory, and the fields of vaccinomics and adversomics. Dr. Poland holds the academic rank of professor of medicine and infectious diseases and molecular pharmacology and experimental therapeutics. He is the founding president of the Edward Jenner Vaccine Society and is Editor-in-Chief for the journal “Vaccine.” Dr. Poland is also the 2013 recipient of the Mayo Distinguished Investigator award by the Mayo Board of Trustees, and the 2012 recipient of the Mayo Clinic Department of Medicine Lifetime Research Achievement Award. In 2012, Dr. Poland was named in the top 25 vaccine influencers in the world. In February 2013, he was nominated for membership in the Institute of Medicine (IOM). In addition, he received an NIH MERIT Award, an honor accorded to less than 5% of the nation’s NIH-funded investigators. Dr. Poland was awarded the Secretary of Defense Award for Excellence in December 2008. In 2008, he was named a Master of the American College of Physicians. Dr. Poland received the Hsu prize in International Infectious Disease Epidemiology in 2007, and the Charles Merieux Lifetime Achievement Award in Vaccinology from the National Foundation for Infectious Diseases in May 2006. In December 2006, Dr. Poland was elected President of the Defense Health Board, serving two terms. In 2005 he was awarded an honorary Doctor of Humane Letters by Illinois Wesleyan University, his alma mater. He was appointed as the Mary Lowell Leary Professor in Medicine (the highest academic distinction for a faculty member) by Mayo Clinic’s Board of Trustees in 2004. In May 2003, he was awarded the Secretary of Defense Medal for Outstanding Public Service for his leadership in writing the Department of Defense’s bioterrorism countermeasures. Since 2004, Dr. Poland has served on the Infectious Diseases Society of America (IDSA) Taskforce on Pandemic Influenza, and chaired the American College of Physician’s Adult Immunization Advisory Board. Dr. Poland received the inaugural Gold Medal from the Spanish Vaccinology Society in 2001. He is the immediate past president of the Department of Defense’s Defense Health Board and the Armed Forces Epidemiological Board. Dr. Poland participates on many national and academic review committees has published over 485 peer-reviewed scientific articles and book chapters. He has received over $180 million in federal funding for his research thus far in his career. Dr. Poland received his medical degree from the Southern Illinois University School of Medicine in Springfield, Ill., and completed his residency and advanced post-graduate work at the University of Minnesota/Abbott-Northwestern Hospital, Minneapolis, Minnesota.
Gregory A. Poland, MD, MACP
Mary Lowell Leary Endowed Professor of Medicine, Infectious Diseases, Molecular Pharmacology and Experimental Therapeutics;
Director, Mayo Vaccine Research Group
Mayo Clinic, Rochester, Minnesota, USA
USA Councilor: Gregory C. Gray, MD, MPH, FIDSA
Gregory C. Gray MD, MPH, FIDSA is a Professor at Duke University with 3 affiliations: the Division of Infectious Diseases in Duke University’s School of Medicine, Duke Global Health Institute, and Duke Nicholas School of the Environment. He also serves part-time as a Professor in the Program in Emerging Infectious Diseases at Duke-NUS Graduate Medical School, Singapore and as a Professor of Global Health at Duke Kunshan University in China. He has visiting professorship positions in six other academic institutions in China, Romania, Australia, and the USA. His medical boards are in Preventive Medicine and Public Health. Dr. Gray has conducted diverse epidemiological studies of infectious diseases for 25 years in 5 continents. Much of his work has involved identifying risk factors for occupational diseases, particularly for infectious diseases. He has studied numerous occupational groups including farmers, animal breeders, veterinarians, military personnel, turkey workers, poultry workers, horse workers, hunters, and pig workers. A strong supporter for the One Health approach, he has won multiple One Health research and training grants, established two centers of One Health (USA & Romania) and developed 4 graduate programs in One Health (PhD, MHS, Certificate and Program). He has mentored more than 50 graduate students, postdocs, and international scholars in research and often guides their work to peer-reviewed publication. He has served on numerous national expert advisory committees including those associated with the US Armed Forces Epidemiological Board, the Infectious Disease Society of America, and the Institute of Medicine. He has authored more than 260 scientific reports and book chapters in the peer-reviewed medical literature. Currently, he serves on the Editorial Board for the journals Influenza and Other Respiratory Viruses and Tropical Diseases,Travel Medicine and Vaccines.
New affiliations as of August 1, 2014
Gregory C. Gray, MD, MPH, FIDSA
Duke University School of Medicine
Duke Infectious Diseases & Duke Global Health Institute
315 Trent Dr.
Durham, NC 27710
ID Divn phone 919-684-6854
Professor, Program in Emerging Infectious Diseases
Duke-NUS Graduate Medical School Singapore
8 College Road
School phone 6515-7666 Email: email@example.com
Professor, Global Health Duke-Kunshan University China No. 8 Duke Avenue Kunshan, Jiangsu, China 21536 +86-400-892-0508
EUROPEAN Councilor: Prof. Bernard A. M. Van der Zeijst, Ph.D.
B.A.M. (Ben) van der Zeijst PhD is affiliated to the Leiden University Medical Center (LUMC) as emeritus professor ‘Vaccines and Vaccination’ (http://goo.gl/A6ftAs). His present activities in research are designing new approaches for vaccine development and immunotherapy, both for infectious diseases and cancer. In teaching, to train young researchers in mastering all aspects of vaccine development, from discovery to licensing and post marketing surveillance. He is coordinator of the EU project VacTrain (www.vactrain.eu). He is also involved in outreach activities by organizing training courses and running a Dutch website on vaccines for GP’s and the general public (www.knvm.org/vaccinologie ). Finally, he assists national an international research councils in evaluating research proposals and research programs.
Full details about his education, professional experience and publications can be found in his CV (https://goo.gl/A11WaK ). In short after his MSc he started as a researcher in molecular biology, resulting in a PhD in 1972. Then he did research in both virology and bacteriology at the School of Veterinary Medicine in Utrecht (The Netherlands). In 1985 he was appointed to professor and chair with increasing managerial responsibilities. In 1997 he moved to the National Institute of Public Health and the Environment (RIVM) in Bilthoven to direct the vaccine activities. He was co-founder of the Netherlands Vaccine Institute, from which he retired in 2009.
AUSTRALIAN Councilor: Dr. David Durrheim, Ph.D., MPH & TM, MBChB, FACTM, FAFPHM
Dr. David Durrheim is Professor of Public Health Medicine at the University of Newcastle in Australia. He is a member of a number of SAGE (Strategic Advisory Group of Experts to the World Health Organisation) working groups and chairs the Measles Verification Commission for the Western Pacific Region. He is also Director of Health Protection of Hunter New England Area Health Service in Australia.Professor Durrheim’s focus is on novel infectious disease surveillance methods, control of vaccine preventable diseases and strategies for reducing inequity in public health service delivery. He has served as an expert advisor and consultant to WHO programs in African and Pacific Regions, and he has served as the Director of a World Health Organization Collaborating Center in Vectorborne Diseases. Professor Durrheim is a strong advocate for equitable global access to effective public health measures, particularly immunization.
Dr. David Durrheim, Ph.D., MPH&TM, MBChB, FACTM, FAFPHM
Director Health Protection
Professor of Public Health Medicine at University of Newcastle
Locked Bag 10, Wallsend NSW, Australia, 2287 firstname.lastname@example.org